SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 49 filers reported holding SURFACE ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $55,000 | -45.5% | 18,852 | -10.8% | 0.00% | – |
| Q4 2021 | $101,000 | -94.3% | 21,130 | -91.0% | 0.00% | -100.0% |
| Q3 2021 | $1,776,000 | +1.6% | 234,636 | +0.1% | 0.00% | 0.0% |
| Q2 2021 | $1,748,000 | +4.4% | 234,347 | +9.2% | 0.00% | 0.0% |
| Q1 2021 | $1,674,000 | -41.4% | 214,594 | -30.6% | 0.00% | -50.0% |
| Q4 2020 | $2,857,000 | +23708.3% | 309,170 | +17969.5% | 0.00% | – |
| Q3 2020 | $12,000 | +50.0% | 1,711 | -62.0% | 0.00% | – |
| Q4 2019 | $8,000 | -38.5% | 4,508 | -53.2% | 0.00% | – |
| Q3 2019 | $13,000 | 0.0% | 9,624 | +87.1% | 0.00% | – |
| Q2 2019 | $13,000 | -77.2% | 5,145 | -58.8% | 0.00% | – |
| Q1 2019 | $57,000 | +14.0% | 12,486 | +2.7% | 0.00% | – |
| Q4 2018 | $50,000 | -98.1% | 12,158 | -94.9% | 0.00% | -100.0% |
| Q3 2018 | $2,597,000 | +521.3% | 237,446 | +822.8% | 0.00% | – |
| Q2 2018 | $418,000 | – | 25,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 2,945,453 | $21,972,000 | 3.87% |
| ACT CAPITAL MANAGEMENT, LLC | 170,500 | $1,272,000 | 0.65% |
| Parkman Healthcare Partners LLC | 228,267 | $1,703,000 | 0.37% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 94,539 | $705,000 | 0.31% |
| C M BIDWELL & ASSOCIATES LTD | 33,030 | $246,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 115,147 | $859,000 | 0.10% |
| Knights of Columbus Asset Advisors LLC | 113,594 | $847,000 | 0.08% |
| ARK Investment Management | 4,478,546 | $33,410,000 | 0.06% |
| Ipswich Investment Management Co., Inc. | 32,000 | $239,000 | 0.06% |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 27,400 | $204,000 | 0.04% |